Browse studies

Find your next paid study

5 recruiting studies matching your filters

Safety and Efficacy of OTL78 (Zopocianine), a Prostate-Specific Membrane Antigen (PSMA)-Targeted Fluorescent Agent, for Intraoperative Imaging of Prostate Cancer: A Phase IIb Trial

This study is being done to support the selection of single dose and timing regimen of Zopocianine (OTL78) in combination with Near InfraRed (NIR) fluorescent …

Prostate Cancer SurgeryProstate Cancer Metastatic Disease

Estimated

~$10 – $7,500

Clinton BahlerNCT07725523

Phase 2

Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy (Fezo-ADT Trial)

The goal of this clinical trial is to learn if fezolinetant can treat hot flashes (vasomotor symptoms) in men with prostate cancer undergoing androgen deprivat…

Prostate CancerProstate Cancer (Adenocarcinoma)Prostate Cancer Metastatic Disease+16 more

Estimated

~$10 – $7,500

Phase 2

Novel FAP-targeted Approach to Imaging Patients With or High-risk for Metastatic Prostate Cancer

The goal of this clinical trial is to gain more information about how FAPI (fibroblast activation protein inhibitor) binds to certain type of cells in the tumo…

Prostate Cancer Metastatic DiseaseProstate Cancers

Estimated

~$10 – $6,250

University of Wisconsin, MadisonNCT06675357

Observational

Prospective Evaluation of PSMA PET Imaging in Surveillance Post-Focal Therapy for Prostate Cancer (PSMA-FT Surveillance Study)

This study is about adding PSMA PET (Prostate Specific Membrane Antigen- Positron Emission Tomography) to routine magnetic resonance imaging (MRI) scans to hel…

Prostate Cancer (Adenocarcinoma)Prostate Cancer (Diagnosis)Prostate Cancer Metastatic Disease

Estimated

~$10 – $6,250

University of ChicagoNCT07115914

Observational

Contribution of Race to Nutritional Approach to Lower Cardiovascular Risk Factors in Men Undergoing Androgen Deprivation Therapy

There is a well-documented association between androgen deprivation therapy (ADT) and cardiovascular morbidity. A majority of men on ADT gain weight contributi…

Prostate Cancer Metastatic Disease

Estimated

~$10 – $6,250

University of California, Los AngelesNCT06682390